HARRISBURG, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (NASDAQ: ORRF) (the “Company”) today announced that Adam L. Metz has been promoted to Senior Executive Vice President and Chief Operating Officer of the Company and its subsidiary bank, Orrstown Bank (the "Bank"), effective immediately, with the intent for him to succeed Thomas R. Quinn, Jr. as President and Chief Executive Officer of the Company and the Bank upon Mr. Quinn's retirement on May 25, 2026.

CALGARY, Alberta, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX:CVE) (NYSE:CVE) will release its fourth-quarter and full-year 2024 results on Thursday, February 20, 2025. The news release will provide consolidated fourth-quarter operating and financial information. The company's financial statements will be available on Cenovus's website, cenovus.com.

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ansegedleucel (cema-cel; formerly ALLO-501/A) in relapsed/refractory (R/R) large B-cell lymphoma (LBCL) as a Rapid Communication in the Journal of Clinical Oncology. These results represent the largest dataset of LBCL patients treated with an allogeneic CAR T product and, with a minimum of two years of follow-up, the longest follow-up …

Kissimmee, FL, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Aureus Greenway Holdings Inc. (the “Company”) (NASDAQ: AGH), an owner and operator of daily fee golf country clubs in the state of Florida, announced today the closing of its initial public offering (the “Offering”) of 3,750,000 shares of its common stock at a public offering price of $4.00 per share for total gross proceeds of $15,000,000, before deducting underwriting discounts and other offering expenses. The shares of common stock of the Company began trading on the Nasdaq Capital Market on February 12, 2025, under the ticker symbol “AGH.” The Offering consisted of …

ANN ARBOR, Mich., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on February 11, 2025, the Company granted ten new employees 58,300 restricted stock units (RSUs) under Esperion's 2017 Inducement Equity Incentive Plan.

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Southfield, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that it has delivered a conditional notice of redemption to the trustee for the Company's 6.625% senior notes due 2026 (the “2026 notes”). The notice of redemption calls for the redemption of all of the outstanding $400.0 million aggregate principal amount of 2026 notes (the “redemption”) on February 28, 2025, in accordance with the terms of the indenture governing the 2026 notes. The redemption is conditioned upon the Company's receipt, prior to the redemption …

NORTHVILLE, Mich. , Feb. 13, 2025 /PRNewswire/ -- Cooper-Standard Holdings Inc. (NYSE: CPS) today reported results for the fourth quarter and full year 2024.

New Independent Director Brings decades of strategic expertise in broadband access and cybersecurity to support Actelis Networks' growth New Independent Director Brings decades of strategic expertise in broadband access and cybersecurity to support Actelis Networks' growth

SAN DIEGO and TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed AML, today announced it has entered into a common share purchase agreement and registration rights agreement with an institutional investor. The Committed Equity Facility agreement provides Aptose the right, in its sole option and discretion without obligation, to sell and issue up to $25 million of its common shares (the “Common Shares”) over the course of 24 months to the …

HOUSTON--(BUSINESS WIRE)--Crescent Energy Company (NYSE: CRGY) today announced plans to host a conference call and webcast at 10 a.m. CT, on Thursday, February 27, 2025 to discuss its fourth quarter and full year 2024 financial and operating results, as well as its outlook for 2025. The Company plans to release results after market close on Wednesday, February 26, 2025. The release and supplemental slides will be available on the company's website at www.crescentenergyco.com. Conference Call In.

- Announces Exit of DNA Tagging and Security Products and Services Business Segment - - Workforce Reduction of 20% of Headcount Implemented in January - - GMP Site 1 Facility Complete and Certified for Commercial Operation in January - - Webcast and Conference Call Scheduled for today at 4:30 PM ET - STONY BROOK, NY / ACCESS Newswire / February 13, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today reported financial results for its first quarter of fiscal 2025 ended December 31, 2024. The Company's Form 10-Q, once filed, …

SAN FRANCISCO , Feb. 13, 2025 /PRNewswire/ -- Airbnb, Inc. (NASDAQ: ABNB) has posted a shareholder letter containing its fourth quarter and full year 2024 financial results on its Investor Relations website at https://investors.airbnb.com . Airbnb will host an audio webcast to discuss its results at 1:30 p.m.

Revenue of $11.2M and Positive Adjusted EBITDA for Seventh Consecutive Quarter Strengthened Balance Sheet and improved financial position Significant Progress in Closing EXIM and Bank Financing to support US Manufacturing Expansion and Overall Growth Plans Reaffirms Fiscal 2025 Revenue Guidance Exceeding $60M, Driven by Strong Order Pipeline TORONTO, ONTARIO / ACCESS Newswire / February 13, 2025 / Electrovaya Inc. ("Electrovaya" or the "Company") (NASDAQ:ELVA)(TSX:ELVA), a leading lithium-ion battery technology and manufacturing company, today reported its financial results for the first quarter of the fiscal year ending September 30, 2025 ("Q1 2025"). All dollar amounts are in U.S. dollars unless otherwise …

~Revised FY2024 revenue guidance is $26.3M instead of previous guidance of $24M~~Company expects to provide Q1 '25 guidance in the next two weeks~ MARLBOROUGH, Mass. , Feb. 13, 2025 /PRNewswire/ -- ConnectM Technology Solutions, Inc. (NASDAQ: CNTM) ("ConnectM" or the "Company"), a technology company focused on the electrification economy, today announced a significant upward revision to its previously announced Q4 2024 preliminary revenue guidance of $7 million.

SANTA CLARA, Calif. , Feb. 13, 2025 /PRNewswire/ -- Palo Alto Networks® (NASDAQ: PANW), the global cybersecurity leader, today announced the appointment of Helle Thorning-Schmidt, former prime minister of Denmark, and Ralph Hamers, former chief executive officer of UBS Group AG and ING Group, to the company's board of directors.

BIDU's fourth-quarter 2024 results are likely to disappoint as China's tech giant battles shrinking ad revenues and profit margins.

An increase in revenues driven by solid bond issuances and continuous demand for analytics supports MCO's Q4 earnings.

With Delta shares moving north, we assess the investment worthiness of the stock at current levels.

Seagate Technology Holdings plc STX is trading comparatively cheap from a valuation standpoint. STX is currently trading at a forward 12-month price-to-sales ratio of 2.05X, a discount compared with the Zacks Computer & Technology sector's 6.53X and the Zacks Computer – Integrated Systems industry's 3.27X.